118 related articles for article (PubMed ID: 12486491)
21. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
[TBL] [Abstract][Full Text] [Related]
22. EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression.
Saletu B; Anderer P; Saletu-Zyhlarz GM
Clin EEG Neurosci; 2010 Oct; 41(4):203-10. PubMed ID: 21077572
[TBL] [Abstract][Full Text] [Related]
23. Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.
Saletu B; Hitzenberger G; Grünberger J; Anderer P; Zyhlarz G; Linzmayer L; Rameis H
Int J Clin Pharmacol Ther; 1995 May; 33(5):249-62. PubMed ID: 7655763
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
[TBL] [Abstract][Full Text] [Related]
25. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):362-73. PubMed ID: 3525428
[TBL] [Abstract][Full Text] [Related]
27. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
[TBL] [Abstract][Full Text] [Related]
29. On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies.
Saletu B; Grünberger J; Anderer R
Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):510-24. PubMed ID: 2086492
[TBL] [Abstract][Full Text] [Related]
30. Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.
Saletu B; Grünberger J; Linzmayer L; Anderer P
Psychopharmacology (Berl); 1992; 109(1-2):30-40. PubMed ID: 1365669
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
Saletu B; Grünberger J; Linzmayer L; Anderer P
Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
[TBL] [Abstract][Full Text] [Related]
32. Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies.
Saletu B; Möller HJ; Grünberger J; Deutsch H; Rössner M
Neuropsychobiology; 1990-1991; 24(4):173-84. PubMed ID: 2135708
[TBL] [Abstract][Full Text] [Related]
33. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
Herrmann WM; Schärer E; Wendt G; Delini-Stula A
Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
[TBL] [Abstract][Full Text] [Related]
34. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
[TBL] [Abstract][Full Text] [Related]
35. Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.
Saletu B; Grünberger J; Linzmayer L
Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):269-85. PubMed ID: 6927816
[TBL] [Abstract][Full Text] [Related]
36. Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L; Wittek R
Arch Gerontol Geriatr; 1984 Jul; 3(2):127-46. PubMed ID: 6476974
[TBL] [Abstract][Full Text] [Related]
37. Amantadine infusions in mild dementia: acute double-blind placebo-controlled EEG mapping and psychometric studies.
Saletu B; Anderer P; Semlitsch HV; Grünberger J; Linzmayer L; Chaudhry HR
Arch Gerontol Geriatr; 1992; 15(1):43-58. PubMed ID: 15374380
[TBL] [Abstract][Full Text] [Related]
38. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
Nobuhara K
Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168
[TBL] [Abstract][Full Text] [Related]
39. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies.
Saletu B; Schulz H; Herrmann WM; Anderer P; Shrotriya RC; Vanbrabant E
Pharmacopsychiatry; 1994 Sep; 27(5):189-97. PubMed ID: 7838889
[TBL] [Abstract][Full Text] [Related]
40. Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine.
Saletu B; Grünberger J; Rajna P
Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):369S-383S. PubMed ID: 6407499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
